A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

November 30, 2023

Primary Completion Date

August 29, 2025

Study Completion Date

January 4, 2026

Conditions

Iron Deficiency Anemia

Interventions

DRUG

KER-047

Oral tablet, daily (or every other day) administration

Trial Locations (5)

Royal Adelaide Hospital, Adelaide

Galilee Medical Center, Nahariya

Laniado Hospital - Sanz Medical Center, Netanya

Shamir Medical Center (Assaf Harofeh Medical Center), Zrifin

Hadassah University Medical Center, Jerusalem